XML 78 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Apr. 30, 2013
Apr. 30, 2012
Apr. 30, 2011
Operating activities:      
Net loss $ (63,752) $ (24,329) $ (20,057)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization expense 10,900 3,108 2,311
Stock-based expense 22,453 7,710 4,681
Revaluation of contingent consideration (1,000)    
Bad debt expense 2,859 1,083 482
Excess tax benefit related to stock-based expense (510) (78)  
Changes in operating assets and liabilities:      
Accounts receivable (10,749) (5,566) (4,974)
Prepaid expenses and other current assets (1,766) (1,132) (1,983)
Other non-current assets (432) (298) 94
Accounts payable 974 808 419
Accrued expenses and other current liabilities 13,283 5,176 3,284
Deferred revenue 8,633 13,432 15,049
Other liabilities, long-term (2,699) (234) 47
Net cash used in operating activities (21,806) (320) (647)
Investing activities:      
Acquisitions, net of cash acquired (60,750)    
Purchases of property, equipment and capitalized internal-use software development costs (10,853) (5,119) (2,282)
Purchases of short-term investments (90,828) (50,884)  
Proceeds from maturities of short-term investments 61,310    
Proceeds from sale of short-term investments 10,032    
Increase in restricted cash   (250)  
Net cash used in investing activities (91,089) (56,253) (2,282)
Financing activities:      
Proceeds from initial public offering, net of offering costs   112,778  
Proceeds from follow-on stock offering, net of costs 51,943    
Proceeds from exercise of stock options 11,226 3,049 2,068
Excess tax benefit related to stock-based expense 510 78  
Net cash provided by financing activities 63,679 115,905 2,068
Effect of exchange rate fluctuations on cash and cash equivalents (106) (15) (125)
Net change in cash and cash equivalents (49,322) 59,317 (986)
Cash and cash equivalents at beginning of period 74,367 15,050 16,036
Cash and cash equivalents at end of period 25,045 74,367 15,050
Supplemental disclosure of other cash flow information:      
Cash paid for income taxes 440 330 523
Supplemental disclosure of non-cash investing and financing activities:      
Purchase of intangible asset recorded in accrued expenses and other current liabilities 705    
Accretion of redeemable convertible preferred stock   38 46
Issuance of stock for acquisition $ 125,497